Laboratorio Reig Jofre SA
MAD:RJF

Watchlist Manager
Laboratorio Reig Jofre SA Logo
Laboratorio Reig Jofre SA
MAD:RJF
Watchlist
Price: 2.55 EUR -0.78%
Market Cap: 204.2m EUR
Have any thoughts about
Laboratorio Reig Jofre SA?
Write Note

Laboratorio Reig Jofre SA
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Laboratorio Reig Jofre SA
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Laboratorio Reig Jofre SA
MAD:RJF
Revenue
€411.9m
CAGR 3-Years
21%
CAGR 5-Years
8%
CAGR 10-Years
30%
Almirall SA
MAD:ALM
Revenue
€1.4B
CAGR 3-Years
5%
CAGR 5-Years
2%
CAGR 10-Years
6%
Laboratorios Farmaceuticos ROVI SA
MAD:ROVI
Revenue
€1B
CAGR 3-Years
7%
CAGR 5-Years
15%
CAGR 10-Years
16%
F
Faes Farma SA
MAD:FAE
Revenue
€487.4m
CAGR 3-Years
8%
CAGR 5-Years
-1%
CAGR 10-Years
11%
No Stocks Found

Laboratorio Reig Jofre SA
Glance View

Market Cap
204.2m EUR
Industry
Pharmaceuticals

Laboratorio Reig Jofre SA engages in the research, development, manufacture, and trade of pharmaceutical drugs. The company is headquartered in Sant Joan Despi, Barcelona and currently employs 1,152 full-time employees. The company went IPO on 2006-11-07. The Company’s activities are divided into four business divisions: Industrial Services, providing production services for third parties; Pharma, selling own pharmaceuticals under a range of brands, such as Reig Jofre, Medea, Orravan, Bioglan and Sala; Reaserch and Development (R&D) and Regulatory, including the development of indications for existing molecules, as well as generics and molecular diagnostics, among others; and Biotech, offering biopharmaceutical support services, such as analytical and process development, quality control and assurance, as well as stability studies. The firm also provides nutritional cosmetics, and food supplements, among others. The company operates worldwide in Europe, Africa, the Americas, Australia and Asia through a number of subsidiaries, including Chiesi Espana SA and Oryzon Genomics SA.

RJF Intrinsic Value
2.99 EUR
Undervaluation 15%
Intrinsic Value
Price

See Also

What is Laboratorio Reig Jofre SA's Revenue?
Revenue
411.9m EUR

Based on the financial report for Sep 30, 2024, Laboratorio Reig Jofre SA's Revenue amounts to 411.9m EUR.

What is Laboratorio Reig Jofre SA's Revenue growth rate?
Revenue CAGR 10Y
30%

Over the last year, the Revenue growth was 10%. The average annual Revenue growth rates for Laboratorio Reig Jofre SA have been 21% over the past three years , 8% over the past five years , and 30% over the past ten years .

Back to Top